About
ProTom International is a healthcare technology company dedicated to developing cost-effective proton therapy systems to enhance cancer treatment. Their flagship product, the Radiance 330® Proton Therapy System, is a compact and modular platform designed for integration within existing radiation oncology departments. It features advanced pencil beam scanning technology and a synchrotron particle accelerator, providing clinical treatment energies suitable for various applications. The company focuses on expanding the accessibility of proton therapy through innovative solutions and sustainable revenue models, including long-term service contracts. ProTom International licenses its technology to ProTom Asia Limited, which has exclusive rights in several regions, including China and parts of Asia and Africa. Their target market includes hospitals and cancer treatment centers looking to adopt or enhance their proton therapy capabilities. ProTom International is committed to raising the standard of cancer care through its advanced technology and expertise.
Technologies
Keywords
Company Information
-
Employees 23
-
Founded 2008
-
Annual Revenue $1000000
-
Total Funding $31796000
Location
3 Gill St, Woburn, Massachusetts, United States, 01801-1720